{"id":7952,"date":"2019-08-28T05:30:16","date_gmt":"2019-08-28T10:30:16","guid":{"rendered":"https:\/\/www.underconsideration.com\/brandnew\/archives\/new_logo_and_identity_for_sage_therapeutics_by_wolff_olins.php"},"modified":"2019-08-28T05:30:16","modified_gmt":"2019-08-28T10:30:16","slug":"new_logo_and_identity_for_sage_therapeutics_by_wolff_olins","status":"publish","type":"post","link":"https:\/\/www.underconsideration.com\/brandnew\/archives\/new_logo_and_identity_for_sage_therapeutics_by_wolff_olins.php","title":{"rendered":"New Logo and Identity for Sage Therapeutics by Wolff Olins"},"content":{"rendered":"<p>(Est. 2010) &#8220;<a href=\"https:\/\/www.sagerx.com\/\" target=\"_blank\" rel=\"noopener noreferrer\">Sage Therapeutics<\/a> is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain. We are pursuing new pathways with the goal of improving brain health and our depression, neurology and neuropsychiatry franchise programs aim to change how brain disorders are thought about and treated. Our mission is to make medicines that matter so people can get better, sooner.&#8221;<\/p>\n<!--more--><figure class=\"full\">\n<img src=\"https:\/\/www.underconsideration.com\/brandnew\/archives\/sage_therapeutics_logo.png\" alt=\"New Logo and Identity for Sage Therapeutics by Wolff Olins\" \/>\n<figcaption>Logo.<\/figcaption>\n<\/figure>\n<figure class=\"full\">\n<img src=\"https:\/\/www.underconsideration.com\/brandnew\/archives\/sage_therapeutics_brain_zoom.gif\" alt=\"New Logo and Identity for Sage Therapeutics by Wolff Olins\" \/>\n<figcaption>Brain zoom graphic.<\/figcaption>\n<\/figure>\n<figure class=\"full\">\n<img src=\"https:\/\/www.underconsideration.com\/brandnew\/archives\/sage_therapeutics_graphic_treatment.jpg\" alt=\"New Logo and Identity for Sage Therapeutics by Wolff Olins\" \/>\n<figcaption>Graphic\/photo treatment.<\/figcaption>\n<\/figure>\n<figure class=\"full\">\n<img src=\"https:\/\/www.underconsideration.com\/brandnew\/archives\/sage_therapeutics_magazine.jpg\" alt=\"New Logo and Identity for Sage Therapeutics by Wolff Olins\" \/>\n<figcaption>Magazine.<\/figcaption>\n<\/figure>\n<figure class=\"full\">\n<img src=\"https:\/\/www.underconsideration.com\/brandnew\/archives\/sage_therapeutics_website.jpg\" alt=\"New Logo and Identity for Sage Therapeutics by Wolff Olins\" \/>\n<hr \/>\n<img src=\"https:\/\/www.underconsideration.com\/brandnew\/archives\/sage_therapeutics_mobile.jpg\" alt=\"New Logo and Identity for Sage Therapeutics by Wolff Olins\" \/>\n<figcaption>Online presence.<\/figcaption>\n<\/figure>\n<figure class=\"full\">\n<img src=\"https:\/\/www.underconsideration.com\/brandnew\/archives\/sage_therapeutics_wildposting.jpg\" alt=\"New Logo and Identity for Sage Therapeutics by Wolff Olins\" \/>\n<figcaption>Posters.<\/figcaption>\n<\/figure>\n<figure class=\"full\">\n<img src=\"https:\/\/www.underconsideration.com\/brandnew\/archives\/sage_therapeutics_billboard.jpg\" alt=\"New Logo and Identity for Sage Therapeutics by Wolff Olins\" \/>\n<figcaption>Billboard.<\/figcaption>\n<\/figure>\n<figure class=\"full\">\n<img src=\"https:\/\/www.underconsideration.com\/brandnew\/archives\/sage_therapeutics_subway.jpg\" alt=\"New Logo and Identity for Sage Therapeutics by Wolff Olins\" \/>\n<figcaption>Subway ads.<\/figcaption>\n<\/figure>\n<figure class=\"full\">\n<img src=\"https:\/\/www.underconsideration.com\/brandnew\/archives\/sage_therapeutics_banners.jpg\" alt=\"New Logo and Identity for Sage Therapeutics by Wolff Olins\" \/>\n<figcaption>Banners.<\/figcaption>\n<\/figure>\n<figure class=\"full\">\n<img src=\"https:\/\/www.underconsideration.com\/brandnew\/archives\/sage_therapeutics_swag.jpg\" alt=\"New Logo and Identity for Sage Therapeutics by Wolff Olins\" \/>\n<figcaption>Swag.<\/figcaption>\n<\/figure>\n<figure class=\"full\"><div class=\"video-container\"><iframe src=\"https:\/\/player.vimeo.com\/video\/355409412?title=0&#038;byline=0&#038;portrait=0\" width=\"360\" height=\"203\" frameborder=\"0\" webkitallowfullscreen mozallowfullscreen allowfullscreen><\/iframe><\/div>\n<figcaption>Brand and identity introduction.<\/figcaption>\n<\/figure>","protected":false},"excerpt":{"rendered":"(Est. 2010) &quot;Sage Therapeutics is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain. We are pursuing new pathways with the goal of improving brain health&#8230;","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"episode_type":"","audio_file":"","duration":"","filesize":"","date_recorded":"","explicit":"","block":"","filesize_raw":""},"categories":[9,72,25],"tags":[39,41,33,180],"_links":{"self":[{"href":"https:\/\/www.underconsideration.com\/brandnew\/wp-json\/wp\/v2\/posts\/7952"}],"collection":[{"href":"https:\/\/www.underconsideration.com\/brandnew\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.underconsideration.com\/brandnew\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.underconsideration.com\/brandnew\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.underconsideration.com\/brandnew\/wp-json\/wp\/v2\/comments?post=7952"}],"version-history":[{"count":0,"href":"https:\/\/www.underconsideration.com\/brandnew\/wp-json\/wp\/v2\/posts\/7952\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.underconsideration.com\/brandnew\/wp-json\/wp\/v2\/media?parent=7952"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.underconsideration.com\/brandnew\/wp-json\/wp\/v2\/categories?post=7952"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.underconsideration.com\/brandnew\/wp-json\/wp\/v2\/tags?post=7952"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}